Astrana Health (ASTH) late Thursday reported a Q4 net loss of $0.15 per diluted share, compared with earnings of $0.26 a year earlier.
Analysts polled by FactSet expected earnings of $0.10.
Revenue for the quarter ended Dec. 31 was $665.2 million up from $353 million a year earlier.
Analysts surveyed by FactSet expected $617.2 million.
The company expects 2025 revenue in the range of $2.5 billion to $2.7 billion. Analysts expected $2.58 billion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。